This study is a prospective, randomized, controlled clinical trials. 300 patients were randomly divided into 2 groups for its own control study.
Test group: Zhen qishen capsule (2 capsules, Bid) and Oral Supplement of Yuyikang (50g,Bid), a total of 150 people, are used for 42 days continuously.
Placebo group: Zhen qishen capsule placebo (2 capsules, Bid) and Oral Supplement of Yuyikang placebo (50g, Bid), a total of 150 people, are used for 42 days continuously.
The subjects were randomized to AB or BA parallely, and the two groups were given chemotherapy and nutrition.